Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1360 in ART-naive HIV-1 infected adults
NCT00046332Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2002
- Primary completion
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of S-1360 in human immunodeficiency virus type 1 infection (HIV-1), sponsored by GSK. Started Jun 2002; status: completed.
02
Drugs
S-1360
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00046332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00046332.